Form S-1
We note that you have not yet disclosed on which exchange you will apply to list your Class A common stock. Please identify the exchange in your next amendment. Please be advised that we may have additional comments upon receipt and review of an amendment with materially complete disclosures about the listing process, the distribution and the risks associated with it.
No reply letter found.
We note your disclosure on page 76 that, in 2020, you generated 95% of net revenue from the sale of glasses, 2% of net revenue from the sale of contacts, 1% of net revenue from eye exams, and the remaining 2% of net revenue primarily from the sale of eyewear accessories. Please include this disclosure in your prospectus summary.
No reply letter found.
We note your disclosure that the Vision Council defines the U.S. eyewear market in 2020 as an approximately $35 billion industry and your disclosure that this industry includes optical retailers’ revenue from the sales of products (including glasses, sunglasses, and contact lenses) and eye care services provided by vision care professionals, including eye exams.Rest of the question
Given that 95% of your net revenue for 2020 was from the sale of glasses, please balance this disclosure by indicating your addressable market for glasses in the United States.
No reply letter found.
Please balance your prospectus summary with a discussion of the challenges you face in implementing your business plan and growing your business. As examples only, please address the following or tell us why disclosure regarding these examples would not be appropriate: • The FDA has taken the position that your Prescription Check mobile application requires a 510(k) premarket notification; • Vision insuranceRest of the question
comprises a significant majority of overall purchases made in the vision care market, but contributed only 3% of your net revenue for the year ended December 31, 2020; and • Compliance with applicable state laws and regulations regarding the corporate practice of medicine and fee-splitting as you seek to increase the scope of your services.
No reply letter found.
We note your statement that you believe that your NPS is the highest in the optical industry. Please revise your disclosure here and on page 97 to provide the basis for this claim and identify the major competitors you are comparing yourself against in making this statement.Rest of the question
We further note that you refer to your NPS score as 80 here and on page 76, but elsewhere in the document you state that your NPS score is more than 80. Please reconcile your disclosure or advise.
No reply letter found.
We note your statement that you hold your partners to "as high standards as we hold ourselves." We further note your disclosure in Risk Factors that you are substantially reliant on a limited number of suppliers and partners, including one supplier for more than half of the cellulose acetate used in your frames and AWS for cloud computing infrastructure, and that you typically do not enter into long-term contractsRest of the question
with your suppliers and therefore do not have contractual assurances. Please revise your disclosure in Our Stakeholders to specify how you hold your suppliers and partners, including your primary cellulose acetate supplier and AWS, to the same high standards that you hold yourselves and provide clarity on what those standards are.
No reply letter found.
If a significant portion of customers who use prescription glasses or contacts purchase their glasses or contacts from their prescriber, and this represents a material hurdle to your business model and ability to gain market share, please revise to disclose and include appropriate risk factor disclosure.
No reply letter found.
Please revise your disclosure to briefly explain how you have determined that your customers become more valuable over time or advise. In that regard, we note that your statement that your Average Revenue Per Customer has increased by 16% since 2018 does not appear to specify whether new customers are included in this calculation.
No reply letter found.
We see that you include what appear to be several other non-GAAP measures in the filing, including what you refer to as contribution margin, four wall margin, and customer acquisition cost. Please tell us how you considered whether these measures are non-GAAP measures and how your disclosures meet the requirements of Item 10(e) of Regulation S- K.
No reply letter found.
Please revise your disclosure in this risk factor to discuss when your agreement with AWS is scheduled to expire and termination provisions.
No reply letter found.
We note your disclosure regarding your Four Wall Margin and average sales per square foot for the year ended December 31, 2019. Please update this disclosure to add similar disclosure for the fiscal year ended December 31, 2020. Please also describe any known trends or uncertainties that have had, or that you reasonably expect will have, a favorable or unfavorable impact on the these measures.
No reply letter found.
Given your disclosure that you are working on expanding your footprint in optometry/optical services, including providing vision exams, please revise your Business section, where appropriate, to describe your compliance regime for applicable state laws and regulations regarding fee-splitting, corporate practice of medicine and state-specific optical and optometry rules.
No reply letter found.
Please revise your Business section, where appropriate, to provide a more detailed discussion of the supply and manufacturing processes for your glasses and your lenses.
No reply letter found.
Please revise your disclosure in this section to provide the basis for your statement that your employee retention rates are industry-leading.
No reply letter found.
Please revise to briefly explain the concept of unaided brand awareness and how you determined that your unaided brand awareness as of the first quarter of 2021 was 13%.
No reply letter found.
Please revise your disclosure regarding your Prescription Check mobile app to reflect your interactions with the FDA, as discussed on page 39.
No reply letter found.
Please disclose the percentage of outstanding shares that your Class B stockholders must maintain to continue to control the outcome of matters submitted to stockholders for approval.
No reply letter found.
Please revise your disclosure to describe in more detail the transfers of your Class B common stock that will not trigger a mandatory conversion of the Class B common stock in accordance with your Amended Charter. In your revisions, please describe whether the death or incapacity of a holder of Class B common stock or an intra-family transfer of Class B common stock would trigger a mandatory conversion.
No reply letter found.
Please expand your disclosure to discuss the factors your board of directors will consider in determining the objectives and standards by which your public benefit performance will be measured. Please also disclose how shareholders will understand whether you have met those objectives and standards and whether you have developed any key performance metrics to measure success.
No reply letter found.
We note your statement that Goldman Sachs, Morgan Stanley and Allen & Company will not be engaged for investor meetings or to otherwise facilitate or coordinate price discovery activities or sales, except as will be described in a future filing with respect to their role under the applicable stock exchange rules.Rest of the question
Please revise your disclosure to provide clarification on the roles that these entities may perform and to describe how you will inform investors of these activities.
No reply letter found.
We note your disclosure that you have engaged financial advisors with respect to certain other matters relating to the registration of shares of your Class A common stock and listing of your Class A common stock. Supplementally provide us with copies of your agreements with your financial advisors.
No reply letter found.
Please supplementally provide us with copies of all written communications, as defined in Rule 405 under the Securities Act, that you, or anyone authorized to do so on your behalf, present to potential investors in reliance on Section 5(d) of the Securities Act, whether or not they retain copies of the communications.
No reply letter found.
We note your statements that you operate with net zero carbon emissions and are a carbon neutral business. Please tell us whether these statements include the operations of your suppliers and other partners who support your operations. To the extent that these statements does not include such operations, please revise your disclosure to clarify the aspects of your business that are included in this statement.Rest of the question
In addition, to the extent that you rely on carbon offsets in order to operate at net zero carbon emissions, please briefly describe these offsets.
The Company respectfully acknowledges the Staff’s comment and has revised page i of the Registration Statement to remove the claim that it operates with net zero carbon emissions and pages iii, 2, 80 and 113 to describe its carbon offsets. The Company respectfully acknowledges the Staff’s comment and advises the Staff that the statements that the Company is a carbon neutral business take into consideration the operations of suppliers and other partners supporting our operations.Read in the replyRest of the answer
More specifically, the Company measures its carbon footprint by calculating: (i) direct greenhouse gas emissions from sources owned or controlled by the Company, including direct emissions from natural gas combustion at all of its locations, including retail stores, optical labs and offices, or collectively Locations; (ii) electricity indirect emissions, which includes emissions from the generation of electricity at all of its Locations; and (iii) all other indirect emissions. This third category of indirect emissions includes emissions from third-party optical laboratories in Shenzhen, China and in the United States; modes of transport used for daily commute and business travel by the Company’s employees; contract manufacturing of frames, lenses, contact lenses, cases, and accessories products; and fuel combustion associated with modes of transport used to ship the Company’s products. The Company also includes raw materials in this third category and supplier emissions for all product manufacturers (including optical labs). Finally, the Company includes Amazon Web Services emissions for server usage/operations for its website, but does not include emissions for non-product-related suppliers.
The Company also respectfully advises the Staff that it relies on carbon offsets in order to be carbon neutral. The Company partners with Sphera (formerly known as Thinkstep) to measure its carbon footprint as described above. It then purchases carbon offsets and verified emissions reductions via Native, a public benefit corporation, for the full amount of its carbon footprint.
We note your response to prior comment 7. Please revise this section, where appropriate, to clearly state that a significant portion of customers who use prescription glasses or contacts purchase them from their prescriber, as indicated in your response letter, and indicate that your ability to gain market share may depend upon your growth strategies to expand your holistic vision care offerings, including expandingRest of the question
your offering and position in relation to eye exams and vision care.
The Company respectfully acknowledges the Staff’s comment and has revised pages 5 and 116 of the Registration Statement.Read in the reply
Please clarify and confirm whether your disclosure on page 56 stating that “As there has not been a recent sustained history of trading in our common stock in a private placement market prior to listing, NYSE listing rules require that a designated market maker, or DMM, consult with our financial advisors in order to effect a fair and orderly opening of trading of our Class A common stock...” takes into account theRest of the question
multiple rounds (i.e., up to series G) of private market financing/capital raising that have already occurred in connection with the Company’s stock prior to this direct listing. Management's Discussion And Analysis Of Financial Condition And Results Of Operations,
The Company respectfully acknowledges the Staff and confirms that its disclosure on page 56 does not take into account its private market financings. The Company notes that Rule 7.35A(g) of the NYSE Listed Company Manual requires that a designated market maker, or DMM, consult with a financial advisor to the issuer if there has not been a “recent sustained history of trading in a Private Placement Market prior to listing.” Section 102.01B of the NYSE Listed Company Manual defines a Private Placement Market as a trading system for unregistered securities operated by a national securitiesRead in the replyRest of the answer
exchange or a registered broker-dealer. The Company notes for the Staff that its private capital raises were not conducted on a trading system for unregistered securities operated by a national securities exchange, but rather were privately negotiated transactions. Moreover, the Company does not believe that its Series G financing completed in August 2020 or its Tender Offer completed in June 2021 qualify as a “recent sustained history of trading” given these were one-time financing events and not sustained trading. In response to the Staff’s comment, the Company has revised page 59 of the Registration Statement.
We note your response to prior comment 11. Please revise to provide comparable measures to Four Wall Margin and average sales per square foot for the year ended December 31, 2020. To the extent these measures are not precisely comparable to Four Wall Margin and average sales per square foot for the year ended December 31, 2019, please include an explanation of the differences in your revisions.
The Company respectfully acknowledges the Staff’s comment and has revised pages 82 and 125 of the Registration Statement to delete Four Wall Margin and average sales per square foot for the year ended December 31, 2019. The Company has revised this disclosure to include its average retail store targets for these metrics, which it believes is useful for an investors understanding of its retail store level economics.Read in the reply
We note your response to prior comment 17 and re-issue. Please revise the Voting Rights subsection of Description of Capital Stock to disclose the percentage of outstanding shares that your Class B stockholders must maintain to continue to control the outcome of matters submitted to stockholders for approval. We further note your revised disclosure on page 60.Rest of the question
Please advise whether you will be a controlled company under NYSE rules. If so, please include appropriate disclosure on the prospectus cover page, in the Prospectus Summary, provide risk factor disclosure of this status and disclose the corporate governance exemptions available to a controlled company. To the extent you will be a controlled company, the cover page and Prospectus Summary disclosure should include the identity of your controlling stockholder(s), the amount of voting power the controlling stockholder(s) will own following the completion of the offering and whether you intend to rely on any exemptions from the corporate governance requirements that are available to controlled companies. Plan of Distribution, page 178
The Company respectfully acknowledges the Staff’s comment and has revised page 175 of the Registration Statement to build in disclosure for the percentage of outstanding shares that its Class B stockholders must maintain to continue to control the outcome of matters submitted to stockholders for approval, and will provide such number in the next pre-effective amendment to the Registration Statement.Read in the replyRest of the answer
The Company further notes for the Staff that it will not qualify as a controlled company under NYSE rules as there is no individual or group that holds over 50% of the voting power for the election of its directors.
Please revise the top paragraph on page 179 to explain the purpose and need for three financial advisors to provide the DMM with the your fair value per share given that this data is already included in the stock valuation report that will have already been provided to the DMM/exchange (and even though the valuation/report is independently prepared without any assistance/input by the financial advisors) and givenRest of the question
that historical per share price information is already contained in the “Sale Price History of Our Common Stock” section of the prospectus.
The Company respectfully acknowledges the Staff’s comment and has revised pages 190 to 191 of the Registration Statement to clarify that the DMM, in consultation with the financial advisors, is expected to consider the information in the section titled “Sale Price History of Our Capital Stock” in establishing the opening public price, but that the financial advisors are not necessarily providing this information to the DMM.Read in the replyRest of the answer
The Company further notes that in accordance with section 102.01B of the NYSE Listed Company Manual, it is the Company’s obligation to provide the NYSE its valuation evidencing a market value of publicly-held shares of at least $250,000,000 and, as such, in response to the Staff’s comment the Company has deleted the disclosure regarding the Company’s financial advisors providing such information to the DMM.
Please provide us with your analysis as to whether a consent is required under Section 7(a) of the Securities Act and Securities Act Rule 436 for the disclosure of your Class A common stock and Class B common stock valuations as determined by the independent third party referenced in this section.
The Company respectfully acknowledges the Staff’s comment and notes that it has deleted the reference to the common stock valuation in response to Comment 6 above given that the Company will provide this valuation directly to the NYSE solely for the purpose of complying with Section 102.01B of the NYSE Listed Company Manual.Read in the reply
* * *
We hope the foregoing answers are responsive to your comments. Please do not hesitate to contact me by telephone at (212) 906-1281 with any questions or comments regarding this correspondence.
We refer to the letter from your co-CEOs. Please revise your presentation so that the letter does not appear in the forepart of the registration statement prior to your Summary. Prospectus Summary, page 1
The Company respectfully acknowledges the Staff’s comment and has moved the letter accordingly.Read in the reply
Please relocate the "Warby Parker Snapshot" graphics so that they do not appear prior to the first page of the Prospectus Summary. Please also revise the graphics to show a balanced presentation of your business.Rest of the question
For instance, and without limitation, present your recent net losses and accumulated deficit with equal prominence to your net revenue and net revenue growth presentation and revise the footnote accompanying the net revenue and net revenue growth measures so that it appears directly below both numbers in an equivalent font size. Also remove the four-wall margin graphic which the footnote indicates is a target.
The Company respectfully acknowledges the Staff’s comment and has removed the “Warby Parker Snapshot” graphic in Submission No. 4.Read in the reply
Please revise the Overview subsection of the Prospectus Summary and the "Who We Are Today" subsection of the Business section to reflect your disclosure elsewhere in the prospectus that your co-CEOs will control any action requiring the approval of your stockholders.
The Company respectfully acknowledges the Staff’s comment and has revised pages 12 and 122 of Submission No. 4Read in the reply
We note your claim that your Buy a Pair, Give a Pair program has increased earning potential for low-income households by more than an estimated $1 billion. Please revise your disclosure within the Overview subsection of the Prospectus Summary to clearly describe how this estimate was calculated and discuss any relevant limitations related to this estimate.
The Company respectfully acknowledges the Staff’s comment and has removed the disclosure from Submission No. 4.Read in the reply
Please revise the Prospectus Summary to briefly define the term NPS the first time it is used in the Summary.
The Company respectfully acknowledges the Staff’s comment and has revised page 7 of Submission No. 4.Read in the reply
We note your revisions summarizing additional results from your biannual Employee Engagement Survey. Please revise your disclosure here and on page 113 to state what percentage of your employees submitted responses to the survey.
The Company respectfully acknowledges the Staff’s comment and has revised pages 7, 86, and 122 of Submission No. 4.Read in the reply
We note your statement that by selling your products "at a fraction" of the price of many of your competitors, you pass savings on to your customers. Please revise your disclosure in this subsection, as well as on pages 80, 82, 111 and 114, to provide the quantitative support for your claim so that investors can better understand and assess the statement.Rest of the question
In your revisions, please clarify if you are referring to your online-only competitors, competitors with retail stores or both.
The Company respectfully acknowledges the Staff’s comment and has revised pages 7, 78, 86, 120, and 124 of Submission No. 4.Read in the reply
We note your response to prior comment 2 and your revised disclosure indicating that the majority of your customers obtain their prescriptions from non-Warby Parker doctors, which underscores your opportunity to expand your optometric and telehealth services. Elsewhere in the registration statement, you disclose that you receive 3% of your revenues from vision insurance.Rest of the question
Please revise your disclosure in this subsection on pages 5 and 116 to state whether insurers currently generally cover your optometric and telehealth services. To the extent that insurers do not cover your optometric and telehealth services, please revise this subsection to discuss any associated challenges with your plans to expand these services.
The Company respectfully acknowledges the Staff’s comment and has revised pages 10 and 126 of Submission No. 4.Read in the reply
With respect to “Customer Acquisition Cost,” please tell us whether the definition you present is commonly understood in the industry to measure costs against Active Customers as opposed to costs against newly acquired customers.Rest of the question
To the extent that your definition differs from the one commonly used by other retailers, please tell us: • what consideration you have given to whether use of the term “Customer Acquisition Cost” could result in confusion to investors; • why management assesses the business using Active Customers; • whether management also assesses performance by measuring costs against new customers and, • noting your disclosure at the bottom of page 88 and top of page 89, what were the costs to acquire new customers during the 2018-2020 period.
The Company respectfully acknowledges the Staff’s comment. The Company believes that, based on the Company’s business model and industry, the most accurate measure of customer acquisition costs includes both new and returning customers, which is calculated by dividing total marketing expenses by Active Customers in a given period. This is primarily due to the fact that the repeat purchase cycle to buy a new pair of glasses is once every two to two-and-a-half years as described on page 10 of the Registration Statement.Read in the replyRest of the answer
Management assesses the overall efficacy of its marketing efforts based on this metric.
Retailers with physical stores typically do not disclose customer acquisition costs and instead provide insight at times into total marketing expenses or specific marketing programs. In contrast, many online businesses who report customer acquisition costs typically allocate all marketing expenses only to new customers. This is often the case where the online business has a subscription-based business model or where purchase frequency occurs by the same customer multiple times a year. This allocation of marketing spend presumes that only new customers cost money to acquire, but all returning customers are “free.” In the case of the Company’s business and the eyeglass industry, which is transaction-based and not subscription-based, and where the repeat purchase cycle is over two years, the Company does not believe that returning customers are free. The Company deploys marketing spend across both online channels like search engine marketing and more traditional channels like television advertising in an effort to generate demand and purchase activity from both new and returning customers. Thus, the Company assesses its marketing spend and the per customer costs associated with such spend as applicable to both new and returning customers, instead of solely new customers. The Company does not believe that this definition is confusing to investors as the Company clearly define this calculation in the Glossary.
The Company also provides all the inputs in the Registration Statement to enable an investor to calculate customer acquisition costs attributable to new customers only. The Company discloses (a) net revenue and (b) marketing expense as a percent of net revenue, and by multiplying these two numbers investors can calculate (c) total marketing expense. The Company also discloses (a) Active Customers and (b) new customers as a percent of Active Customers, and by multiplying these two numbers investors can calculate (c) the number of new customers. To calculate customer acquisition costs attributable to new customers, investors can divide total marketing expense by the number of new customers. For the years ended December 31, 2018, 2019 and 2020, customer acquisition costs attributable to new customers were $41, $44, and $70, respectively. The Company also advises the Staff that management does not regularly review customer acquisition costs attributable to new customers, and instead assesses its business performance by reviewing Customer Acquisition Cost attributable to total Active Customers, as referenced in the Registration Statement. The Company has endeavored to express customer acquisition costs to investors in the same manner in which the Company assesses performance, deploys marketing spend and discusses marketing costs internally.
We note your inclusion of a new metric, Customer Market Share, on page 124. Please revise your disclosure in this subsection to include (i) a clear definition of the metric and how it is calculated, (ii) why the metric provides useful information to investors and (iii) how management uses this metric in managing or monitoring the performance of your business.Rest of the question
Please also disclose any estimates or assumptions underlying the metric or its calculation. For guidance, please refer to SEC Release No. 33-10751. Plan of Distribution, page 191
The Company respectfully acknowledges the Staff’s comment and has revised pages 4 and 134 of Submission No. 4.Read in the reply
We note your response to prior comment 7 and revised disclosure. With a view to disclosure, please tell us whether the independent common stock valuation will be provided to the DMM at any time during the direct listing process. If there is uncertainty, please explain.
The Company respectfully acknowledges the Staff’s comment and advises the Staff that, based on information provided by the New York Stock Exchange, the Company understands that the independent common stock valuation will not be provided to the DMM at any time during the direct listing process.Read in the reply
With reference to the guidance contained in Compliance and Disclosure Interpretations, Securities Act Forms, Question 101.02, we note that graphic presentations should not obscure other prospectus disclosure. Accordingly, please tell us why you believe it is appropriate to include ten pages of graphics and accompanying text in a narrative that precedes the Summary section.Rest of the question
In addition, please refer to the above referenced Compliance and Disclosure Interpretation and revise the text so that it does not focus on only the most favorable aspects your business.
The Company respectfully acknowledges the Staff’s comment and has revised the front cover graphics of Submission No. 4.Read in the reply
We note the disclosures throughout your prospectus regarding your company’s election to have its performance, accountability and transparency measured against criteria established by B Lab and B Lab’s designation of the company as a “Certified B Corporation.” Please file the Rule 436 consent of B Lab to being named in the registration statement and to the references to its designation of the company as a “CertifiedRest of the question
B Corporation.”
The Company respectfully acknowledges the Staff’s comment and has removed references to the Company’s designation as a “Certified B Corporation” in Submission No. 4.Read in the reply
* * *
We hope the foregoing answers are responsive to your comments. Please do not hesitate to contact me by telephone at (212) 906-1281 with any questions or comments regarding this correspondence.
We note your disclosure here and in other locations that the Co-Founders and Co-Chief Executive Officers will hold outstanding shares of your Class B common stock, and exercise voting control over shares of your Class A common stock, representing a total of approximately 48% of the voting power of your outstanding capital stock and that as a result, Mr. Blumenthal and Mr.Rest of the question
Gilboa will be able to exercise significant influence, and may be able to exercise significant control in the future, over actions requiring the approval of your stockholders, including the election of your board of directors, the adoption of amendments to your Amended Charter and Amended Bylaws and the approval of any merger, consolidation, sale of all or substantially all of your assets or other major corporate transaction. Please revise this disclosure, and your similar disclosure throughout, to also indicate, if true, that Mr. Blumenthal and Mr. Gilboa will be able to control such actions if they exercise their outstanding options exercisable for additional shares of your Class B stock and chose to act together on such actions.
The Company respectfully acknowledges the Staff’s comment and has revised the cover page and pages 12, 14, 67, and 122 of Amendment No. 2.Read in the reply
* * *
We hope the foregoing answers are responsive to your comments. Please do not hesitate to contact me by telephone at (212) 906-1281 with any questions or comments regarding this correspondence.
Also in this review: company letter, Sep 15, 2021